211
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression

, , , , , , , ORCID Icon, ORCID Icon, , & show all
Pages 3079-3087 | Published online: 06 Nov 2019

References

  • Culpepper L, Lam RW, McIntyre RS. Cognitive impairment in patients with depression: awareness, assessment, and management. J Clin Psychiatry. 2017;78(9):1383–1394. doi:10.4088/JCP.tk16043ah5c29345866
  • Etkin A, Patenaude B, Song YJ, et al. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Neuropsychopharmacology. 2015;40(6):1332–1342. doi:10.1038/npp.2014.33325547711
  • Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: a review. Encephale. 2002;28(2):97–107.
  • Ishak WW, Greenberg JM, Cohen RM. Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D). J Affect Disord. 2013;151(1):59–65. doi:10.1016/j.jad.2013.05.04823790554
  • Serafini G, Pompili M, Belvederi Murri M, et al. The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression. A Systematic Review. Neuropsychobiology. 2015;71(3):125–139. doi:10.1159/00038135125925699
  • Boes AD, Kelly MS, Trapp NT, Stern AP, Press DZ, Pascual-Leone A. Noninvasive brain stimulation: challenges and opportunities for a new clinical specialty. J Neuropsychiatry Clin Neurosci. 2018;30(3):173–179. doi:10.1176/appi.neuropsych.1711026229685065
  • Neville IS, Hayashi CY, El Hajj SA, Zaninotto AL, Sabino JP, Sousa LM Jr. Repetitive transcranial magnetic stimulation (rTMS) for the cognitive rehabilitation of traumatic brain injury (TBI) victims: study protocol for a randomized controlled trial. Trials. 2015;16:440. doi:10.1186/s13063-015-0944-226438108
  • Hayasaka S, Nakamura M, Noda Y, et al. Lateralized hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression. Psychiatry Clin Neurosci. 2017;71(11):747–758. doi:10.1111/pcn.2017.71.issue-1128631869
  • Nilakantan AS, Mesulam MM, Weintraub S, Karp EL, VanHaerents S, Voss JL. Network-targeted stimulation engages neurobehavioral hallmarks of age-related memory decline. Neurology. 2019;92(20):e2349–e2354. doi:10.1212/WNL.000000000000750230996057
  • Shinba T, Kariya N, Matsuda S. Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy. Psychiatry Clin Neurosci. 2018;72(8):602–610. doi:10.1111/pcn.2018.72.issue-829774621
  • Bae JN, MacFall JR, Krishnan KRR, Payne ME, Steffens DC, Taylor WD. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry. 2006;60:1356–1363. doi:10.1016/j.biopsych.2006.03.05216876144
  • Li CX, Sun XL, Zou K, et al. Voxel based analysis of DTI in depression patients. Int J MRI. 2007;1:43–48.
  • Lim KO, Helpen JA. Neuropsychiatric applications of DTI: a review. NMR Biomed. 2002;15:587–593. doi:10.1002/nbm.78912489105
  • Liu X, Wang YZ, Liu HH, Liu ZN, Zhou WB. Diffusion tensor imaging and resting state functional magnetic resonance imaging on young patients with major depressive disorder. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35(1):25–31. doi:10.3969/j.issn.1672-7347.2010.01.00420130361
  • Yang Q, Huang XB, Hong N, Yu X. White matter microstructural abnormalities in late-life depression. Int Psychogeriatr. 2007;19(4):757–766. doi:10.1017/S104161020700487517346365
  • Scheinost D, Holmes SE, DellaGioia N, et al. Multimodal investigation of network level effects using intrinsic functional connectivity, anatomical covariance, and structure-to-function correlations in unmedicated major depressive disorder. Neuropsychopharmacology. 2018;43(5):1119–1127. doi:10.1038/npp.2017.22928944772
  • Kozel FA, Johnson KA, Nahas Z, et al. Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression. J ECT. 2011;27(1):5–10. doi:10.1097/YCT.0b013e3181e6317d20559144
  • Peng H, Zheng H, Li L, et al. High-frequency rTMS treatment increases white matter FA in the left middle frontal gyrus in young patients with treatment-resistant depression. J Affect Disord. 2012;136(3):249–257. doi:10.1016/j.jad.2011.12.00622217432
  • Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7(0):151–169.4412100
  • Pan S, Liu ZW, Shi S, et al. Hamilton rating scale for depression-24 (HAM-D24) as a novel predictor for diabetic microvascular complications in type 2 diabetes mellitus patients. Psychiatry Res. 2017;258:177–183. doi:10.1016/j.psychres.2017.07.05028774662
  • Avery D, Holtzheimer P, Fawaz W, et al. Repetitive transcranial magnetic stimulation (rTMS) is clinically effective in treatment-resistant major depression. Biol Psychiatry. 2004;55:718.
  • Fitzgerald PB. Repetitive transcranial magnetic stimulation treatment for depression: lots of promise but still lots of questions. Brain Stimul. 2009;2(4):185–187. doi:10.1016/j.brs.2009.08.00520633418
  • Fitzgerald PB, Hoy K, McQueen S, et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology. 2009;34(5):1255–1262. doi:10.1038/npp.2008.23319145228
  • Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd ed Arlington, VA: American Psychiatric Association; 2010.
  • Guse B, Falkai P, Wobrock T. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm (Vienna). 2010;117(1):105–122. doi:10.1007/s00702-009-0333-719859782
  • Fitzgerald PB, Hoy K, Daskalakis ZJ, Kulkarni J. A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress Anxiety. 2009;26(3):229–234. doi:10.1002/da.v26:319105212
  • Boggio PS, Fregni F, Bermpohl F, et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord. 2005;20(9):1178–1184. doi:10.1002/(ISSN)1531-825715895421
  • Arnsten AF, Rubia K. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2012;51(4):356–367. doi:10.1016/j.jaac.2012.01.00822449642
  • Pallanti S, Di Rollo A, Antonini S, Cauli G, Hollander E, Quercioli L. Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response. Neuropsychobiology. 2012;65(4):227–235. doi:10.1159/00033699922653158
  • Alves GS, Karakaya T, Fußer F, et al. Association of microstructural white matter abnormalities with cognitive dysfunction in geriatric patients with major depression. Psychiatry Res. 2012;203(2–3):194–200. doi:10.1016/j.pscychresns.2011.12.00622959814
  • Rizk MM, Rubin-Falcone H, Keilp J, et al. White matter correlates of impaired attention control in major depressive disorder and healthy volunteers. J Affect Disord. 2017;222:103–111. doi:10.1016/j.jad.2017.06.06628688263
  • Stämpfli P, Sommer S, Manoliu A, et al. Subtle white matter alterations in schizophrenia identified with a new measure of fiber density. Sci Rep. 2019;9(1):4636. doi:10.1038/s41598-019-40070-230874571